ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive
ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today released findings from two biotech sector surveys. The first survey focused on global biotech trends and is an update of…